COVID-19 Infection

Infectious Diseases
3
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
1
1
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Vaccine
1100%
+ 3 programs with unclassified modality

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Swedish Orphan Biovitrum
1 program
1
Anakinra plus oSOCPhase 31 trial
Active Trials
NCT04364009TerminatedEst. Nov 2020
R
ResVerlogiXAB - Calgary
1 program
1
ApabetalonePhase 2/31 trial
Active Trials
NCT04894266Terminated1Est. Jun 2022
Roche
RocheSTAVANGER NORWAY, Norway
1 program
1
rhDNase IPhase 11 trial
Active Trials
NCT04409925Completed15Est. Aug 2021
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in EnglandN/AVaccine1 trial
Active Trials
NCT05047822Completed18,373,714Est. Jan 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Swedish Orphan BiovitrumAnakinra plus oSOC
ResVerlogiXApabetalone
RocherhDNase I
AstraZenecaOxford/AstraZeneca COVID-19 Vaccine Effectiveness in England

Clinical Trials (4)

Total enrollment: 18,373,730 patients across 4 trials

NCT04364009Swedish Orphan BiovitrumAnakinra plus oSOC

Anakinra for COVID-19 Respiratory Symptoms

Start: Apr 2020Est. completion: Nov 2020
Phase 3Terminated
NCT04894266ResVerlogiXApabetalone

An Open-Label Study of Apabetalone in Covid Infection

Start: Jan 2022Est. completion: Jun 20221 patients
Phase 2/3Terminated
NCT04409925RocherhDNase I

DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)

Start: Dec 2020Est. completion: Aug 202115 patients
Phase 1Completed
NCT05047822AstraZenecaOxford/AstraZeneca COVID-19 Vaccine Effectiveness in England

Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England

Start: Aug 2021Est. completion: Jan 202318,373,714 patients
N/ACompleted

Related Jobs in Infectious Diseases

Senior Recruiter

Invivyd
New Haven, CT (Northeast preferred)
7h ago
$120K - $160K/yr

Senior Associate Scientist (contract), Upstream Polysaccharide Process Development

VaxCyte
San Carlos, California, United States
9h ago
$56/hr

Senior Associate Scientist (contract), Polysaccharide Analytical Development

VaxCyte
San Carlos, California, United States
10h ago
$56/hr

Director, Program Management

Metaphore Biotechnologies
Somerville, MA USA
13h ago
$179K - $237K/yr

Technician, Operations, DSP/ Technicien(ne) des opérations, DSP

Verona Pharma
CAN - Prince Edward Island - Charlottetown
Yesterday
$47K - $79K/yr

HVAC Maintenance Technician

Verona Pharma
USA - Delaware - Millsboro (Intervet)
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
5 companies competing in this space

Related Indications

HIV Infections(449)COVID-19(223)Hepatitis C(191)Influenza(173)HIV(138)HIV-1-infection(115)Hepatitis C, Chronic(94)Chronic Hepatitis B(93)Chronic Hepatitis C(91)Covid19(79)